National Institute of Allergy and Infectious Diseases-ko ikertzaileekin lankidetzan egindako argitalpenak (24)

2021

  1. Expansion of t regulatory lymphocytes by murine bone marrow dendritic cells previously stimulated with anisakis simplex larval antigens

    Memorias do Instituto Oswaldo Cruz, Vol. 116, Núm. 1, pp. 1-10

2019

  1. Induction of tolerogenic properties by Anisakis larval antigens on murine dendritic cells

    Parasite Immunology, Vol. 41, Núm. 4

2006

  1. Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides

    European Journal of Immunology, Vol. 36, Núm. 12, pp. 3238-3247

  2. The impact of concurrent and treated Ancylostoma ceylanicum hookworm infections on the immunogenicity of a recombinant hookworm vaccine in hamsters

    Journal of Infectious Diseases, Vol. 193, Núm. 1, pp. 155-162

2005

  1. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells

    Infection and Immunity, Vol. 73, Núm. 10, pp. 6620-6628

  2. Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection

    Infection and Immunity, Vol. 73, Núm. 8, pp. 4714-4722

  3. Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials

    Vaccine, Vol. 23, Núm. 39, pp. 4754-4764

  4. Host cytokine production, lymphoproliferation, and antibody responses during the course of Ancylostoma ceylanicum infection in the Golden Syrian hamster

    Infection and Immunity, Vol. 73, Núm. 6, pp. 3402-3407

  5. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice

    Journal of Immunology, Vol. 174, Núm. 5, pp. 2934-2941

2004

  1. Role for CD4+ CD25+ regulatory T cells in reactivation of persistent Leishmaniasis and control of concomitant immunity

    Journal of Experimental Medicine, Vol. 200, Núm. 2, pp. 201-210

2003

  1. Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous leishmaniasis but maintains its potency and durability

    Infection and Immunity, Vol. 71, Núm. 9, pp. 5121-5129

  2. Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection

    Journal of Biological Chemistry, Vol. 278, Núm. 37, pp. 35508-35515

  3. Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice

    Journal of Experimental Medicine, Vol. 198, Núm. 2, pp. 281-291

  4. Immunological and pathological evaluation of rhesus macaques infected with Leishmania major

    Experimental Parasitology, Vol. 103, Núm. 3-4, pp. 160-168

2002

  1. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

    Nature, Vol. 420, Núm. 6915, pp. 502-507

  2. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major

    Journal of Immunology, Vol. 168, Núm. 8, pp. 3992-4000

  3. Optimization of DNA vaccination against cutaneous leishmaniasis

    Vaccine, Vol. 20, Núm. 31-32, pp. 3702-3708

  4. Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4 + and CD8 + T cell responses and protection against Leishmania major infection

    Journal of Experimental Medicine, Vol. 195, Núm. 12, pp. 1565-1573

2001

  1. Correlation between in vitro and in vivo infectivity of Leishmania infantum clones

    Journal of Eukaryotic Microbiology, Vol. 48, Núm. 6, pp. 616-621

  2. Skin dendritic cells in murine cutaneous leishmaniasis

    Immunobiology, Vol. 204, Núm. 5, pp. 590-594